Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

The Golgi sorting motifs of human cytomegalovirus UL138 are not required for latency maintenance.

Gelbmann CB, Kalejta RF.

Virus Res. 2019 Jun 28;270:197646. doi: 10.1016/j.virusres.2019.197646. [Epub ahead of print]

PMID:
31260705
2.

Human Cytomegalovirus Enters the Primary CD34+ Hematopoietic Progenitor Cells Where It Establishes Latency by Macropinocytosis.

Lee JH, Kalejta RF.

J Virol. 2019 Jul 17;93(15). pii: e00452-19. doi: 10.1128/JVI.00452-19. Print 2019 Aug 1.

PMID:
31118259
3.
4.

A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection.

Bristol JA, Djavadian R, Albright ER, Coleman CB, Ohashi M, Hayes M, Romero-Masters JC, Barlow EA, Farrell PJ, Rochford R, Kalejta RF, Johannsen EC, Kenney SC.

PLoS Pathog. 2018 Jul 27;14(7):e1007179. doi: 10.1371/journal.ppat.1007179. eCollection 2018 Jul.

5.

Human Cytomegalovirus Productively Replicates In Vitro in Undifferentiated Oral Epithelial Cells.

Weng C, Lee D, Gelbmann CB, Van Sciver N, Nawandar DM, Kenney SC, Kalejta RF.

J Virol. 2018 Jul 31;92(16). pii: e00903-18. doi: 10.1128/JVI.00903-18. Print 2018 Aug 15.

6.

HCMV Assembly Is Totally Tubular.

Lyon SM, Kalejta RF.

Dev Cell. 2018 Apr 9;45(1):1-2. doi: 10.1016/j.devcel.2018.03.014.

7.

Direct Substrate Identification with an Analog Sensitive (AS) Viral Cyclin-Dependent Kinase (v-Cdk).

Umaña AC, Iwahori S, Kalejta RF.

ACS Chem Biol. 2018 Jan 19;13(1):189-199. doi: 10.1021/acschembio.7b00972. Epub 2017 Dec 19.

9.

Human Cytomegalovirus-Infected Glioblastoma Cells Display Stem Cell-Like Phenotypes.

Liu C, Clark PA, Kuo JS, Kalejta RF.

mSphere. 2017 Jun 21;2(3). pii: e00137-17. doi: 10.1128/mSphere.00137-17. eCollection 2017 May-Jun.

10.

Gender Parity Trends for Invited Speakers at Four Prominent Virology Conference Series.

Kalejta RF, Palmenberg AC.

J Virol. 2017 Jul 27;91(16). pii: e00739-17. doi: 10.1128/JVI.00739-17. Print 2017 Aug 15.

11.

Human cytomegalovirus-encoded viral cyclin-dependent kinase (v-CDK) UL97 phosphorylates and inactivates the retinoblastoma protein-related p107 and p130 proteins.

Iwahori S, Umaña AC, VanDeusen HR, Kalejta RF.

J Biol Chem. 2017 Apr 21;292(16):6583-6599. doi: 10.1074/jbc.M116.773150. Epub 2017 Mar 13.

12.

Mouse Tmem135 mutation reveals a mechanism involving mitochondrial dynamics that leads to age-dependent retinal pathologies.

Lee WH, Higuchi H, Ikeda S, Macke EL, Takimoto T, Pattnaik BR, Liu C, Chu LF, Siepka SM, Krentz KJ, Rubinstein CD, Kalejta RF, Thomson JA, Mullins RF, Takahashi JS, Pinto LH, Ikeda A.

Elife. 2016 Nov 15;5. pii: e19264. doi: 10.7554/eLife.19264.

13.

Sifting and Winnowing through Human Cytomegalovirus Lytic Replication and Latency.

Kalejta RF.

PLoS Pathog. 2016 Sep 22;12(9):e1005607. doi: 10.1371/journal.ppat.1005607. eCollection 2016 Sep. No abstract available.

14.

Canonical and Variant Forms of Histone H3 Are Deposited onto the Human Cytomegalovirus Genome during Lytic and Latent Infections.

Albright ER, Kalejta RF.

J Virol. 2016 Oct 28;90(22):10309-10320. doi: 10.1128/JVI.01220-16. Print 2016 Nov 15.

15.

Long and Short Isoforms of the Human Cytomegalovirus UL138 Protein Silence IE Transcription and Promote Latency.

Lee SH, Caviness K, Albright ER, Lee JH, Gelbmann CB, Rak M, Goodrum F, Kalejta RF.

J Virol. 2016 Sep 29;90(20):9483-94. doi: 10.1128/JVI.01547-16. Print 2016 Oct 15.

16.

Human Cytomegalovirus Can Procure Deoxyribonucleotides for Viral DNA Replication in the Absence of Retinoblastoma Protein Phosphorylation.

Kuny CV, Kalejta RF.

J Virol. 2016 Sep 12;90(19):8634-43. doi: 10.1128/JVI.00731-16. Print 2016 Oct 1.

17.

Cellular defense against latent colonization foiled by human cytomegalovirus UL138 protein.

Lee SH, Albright ER, Lee JH, Jacobs D, Kalejta RF.

Sci Adv. 2015 Nov 27;1(10):e1501164. doi: 10.1126/sciadv.1501164. eCollection 2015 Nov.

18.
19.

Molecular Determinants for the Inactivation of the Retinoblastoma Tumor Suppressor by the Viral Cyclin-dependent Kinase UL97.

Iwahori S, Hakki M, Chou S, Kalejta RF.

J Biol Chem. 2015 Aug 7;290(32):19666-80. doi: 10.1074/jbc.M115.660043. Epub 2015 Jun 21.

20.

The retinoblastoma tumor suppressor promotes efficient human cytomegalovirus lytic replication.

VanDeusen HR, Kalejta RF.

J Virol. 2015 May;89(9):5012-21. doi: 10.1128/JVI.00175-15. Epub 2015 Feb 18.

21.

The 19S proteasome activator promotes human cytomegalovirus immediate early gene expression through proteolytic and nonproteolytic mechanisms.

Winkler LL, Kalejta RF.

J Virol. 2014 Oct;88(20):11782-90. doi: 10.1128/JVI.01720-14. Epub 2014 Jul 30.

22.
23.

Hsp90 inhibitor 17-DMAG decreases expression of conserved herpesvirus protein kinases and reduces virus production in Epstein-Barr virus-infected cells.

Sun X, Bristol JA, Iwahori S, Hagemeier SR, Meng Q, Barlow EA, Fingeroth JD, Tarakanova VL, Kalejta RF, Kenney SC.

J Virol. 2013 Sep;87(18):10126-38. doi: 10.1128/JVI.01671-13. Epub 2013 Jul 10.

24.

Heterologous viral promoters incorporated into the human cytomegalovirus genome are silenced during experimental latency.

Qin Q, Penkert RR, Kalejta RF.

J Virol. 2013 Sep;87(17):9886-94. doi: 10.1128/JVI.01726-13. Epub 2013 Jul 3.

25.

Myeloblastic cell lines mimic some but not all aspects of human cytomegalovirus experimental latency defined in primary CD34+ cell populations.

Albright ER, Kalejta RF.

J Virol. 2013 Sep;87(17):9802-12. doi: 10.1128/JVI.01436-13. Epub 2013 Jul 3.

26.

Human embryonic stem cell lines model experimental human cytomegalovirus latency.

Penkert RR, Kalejta RF.

MBio. 2013 May 28;4(3):e00298-13. doi: 10.1128/mBio.00298-13.

27.

Ubiquitin-independent proteasomal degradation of tumor suppressors by human cytomegalovirus pp71 requires the 19S regulatory particle.

Winkler LL, Hwang J, Kalejta RF.

J Virol. 2013 Apr;87(8):4665-71. doi: 10.1128/JVI.03301-12. Epub 2013 Feb 13.

28.

Tale of a tegument transactivator: the past, present and future of human CMV pp71.

Penkert RR, Kalejta RF.

Future Virol. 2012 Sep 1;7(9):855-869.

29.

BclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infection.

Lee SH, Kalejta RF, Kerry J, Semmes OJ, O'Connor CM, Khan Z, Garcia BA, Shenk T, Murphy E.

Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9575-80. doi: 10.1073/pnas.1207496109. Epub 2012 May 29.

30.

Consensus on the role of human cytomegalovirus in glioblastoma.

Dziurzynski K, Chang SM, Heimberger AB, Kalejta RF, McGregor Dallas SR, Smit M, Soroceanu L, Cobbs CS; HCMV and Gliomas Symposium.

Neuro Oncol. 2012 Mar;14(3):246-55. doi: 10.1093/neuonc/nor227. Epub 2012 Feb 8.

31.

Significant association of multiple human cytomegalovirus genomic Loci with glioblastoma multiforme samples.

Ranganathan P, Clark PA, Kuo JS, Salamat MS, Kalejta RF.

J Virol. 2012 Jan;86(2):854-64. doi: 10.1128/JVI.06097-11. Epub 2011 Nov 16.

32.

In vivo analysis of protein sumoylation induced by a viral protein: Detection of HCMV pp71-induced Daxx sumoylation.

Hwang J, Kalejta RF.

Methods. 2011 Oct;55(2):160-5. doi: 10.1016/j.ymeth.2011.07.004. Epub 2011 Jul 24.

33.

Ubiquitin-independent proteasomal degradation during oncogenic viral infections.

Hwang J, Winkler L, Kalejta RF.

Biochim Biophys Acta. 2011 Dec;1816(2):147-57. doi: 10.1016/j.bbcan.2011.05.005. Epub 2011 Jun 6. Review.

34.

Elongin B-mediated epigenetic alteration of viral chromatin correlates with efficient human cytomegalovirus gene expression and replication.

Hwang J, Saffert RT, Kalejta RF.

MBio. 2011 Mar 29;2(2):e00023-11. doi: 10.1128/mBio.00023-11. Print 2011.

35.

Tegument protein control of latent herpesvirus establishment and animation.

Penkert RR, Kalejta RF.

Herpesviridae. 2011 Feb 8;2(1):3. doi: 10.1186/2042-4280-2-3.

36.

Cyclin-dependent kinase-like function is shared by the beta- and gamma- subset of the conserved herpesvirus protein kinases.

Kuny CV, Chinchilla K, Culbertson MR, Kalejta RF.

PLoS Pathog. 2010 Sep 9;6(9):e1001092. doi: 10.1371/journal.ppat.1001092.

37.
38.

Cellular and viral control over the initial events of human cytomegalovirus experimental latency in CD34+ cells.

Saffert RT, Penkert RR, Kalejta RF.

J Virol. 2010 Jun;84(11):5594-604. doi: 10.1128/JVI.00348-10. Epub 2010 Mar 24.

39.

Simian virus 40 T/t antigens and lamin A/C small interfering RNA rescue the phenotype of an Epstein-Barr virus protein kinase (BGLF4) mutant.

Meng Q, Hagemeier SR, Kuny CV, Kalejta RF, Kenney SC.

J Virol. 2010 May;84(9):4524-33. doi: 10.1128/JVI.02456-09. Epub 2010 Feb 10.

40.

Human papillomavirus 16 E7 inactivator of retinoblastoma family proteins complements human cytomegalovirus lacking UL97 protein kinase.

Kamil JP, Hume AJ, Jurak I, Münger K, Kalejta RF, Coen DM.

Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16823-8. doi: 10.1073/pnas.0901521106. Epub 2009 Sep 15.

41.

Human cytomegalovirus protein pp71 induces Daxx SUMOylation.

Hwang J, Kalejta RF.

J Virol. 2009 Jul;83(13):6591-8. doi: 10.1128/JVI.02639-08. Epub 2009 Apr 15.

42.

Regulation of the retinoblastoma proteins by the human herpesviruses.

Hume AJ, Kalejta RF.

Cell Div. 2009 Jan 15;4:1. doi: 10.1186/1747-1028-4-1.

43.

Simultaneous analysis of the cyan, green, and yellow fluorescent proteins.

Beavis AJ, Kalejta RF.

Curr Protoc Cytom. 2001 May;Chapter 1:Unit 1.16. doi: 10.1002/0471142956.cy0116s16.

PMID:
18770665
44.

Functions of human cytomegalovirus tegument proteins prior to immediate early gene expression.

Kalejta RF.

Curr Top Microbiol Immunol. 2008;325:101-15. Review.

PMID:
18637502
45.

Tegument proteins of human cytomegalovirus.

Kalejta RF.

Microbiol Mol Biol Rev. 2008 Jun;72(2):249-65, table of contents. doi: 10.1128/MMBR.00040-07. Review.

46.

Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function.

Hume AJ, Finkel JS, Kamil JP, Coen DM, Culbertson MR, Kalejta RF.

Science. 2008 May 9;320(5877):797-9. doi: 10.1126/science.1152095.

47.
49.

Supplemental Content

Loading ...
Support Center